Red Tree Venture Capital

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.